Myalgias in myopathies: severity, consequences and type of muscle pain

Myalgias in myopathies: severity, consequences and type of muscle pain - Myalgia in myopathies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033329

Enrollment

200

Registered

2024-01-02

Start date

2024-01-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G71.0 G71.1 G71.2 G71.3 M33.1 M33.2 M33.9

Interventions

Group 1: If the patient consents, he/she will be asked to complete a study-specific questionnaire regarding myalgia. This questionnaire asks about the severity and frequency of the myalgia, the type o

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patient with clinically and instrumentally confirmed myopathy - = 18 years of age - Ability to give consent

Exclusion criteria

Exclusion criteria: - Patient without or with unclear neuromuscular disease without certain classification of the disease - <18 years - Patient unable to give consent

Design outcomes

Primary

Measure	Time frame
Recording the frequency and severity of myalgias in patients with myopathies	—

Secondary

Measure	Time frame
Type of muscle pain (sharp, dull, etc.). Differences in myalgias between inflammatory and hereditary myopathies. Effectiveness of the different pain therapies. Characterization of the pain features of the various myopathies.	—

Countries

Germany

Contacts

Public ContactJana Zschüntzsch

Universitätsmedizin Göttingen, Klinik für Neurologie

j.zschuentzsch@med.uni-goettingen.de+49 551 3965683

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026